Paper326072
Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine.
Clyde DF and 1 other. Am J Trop Med Hyg, 1977. Cited by 64 papers, by iCite.
Cite this record
ConductScience Library. Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine. Papers, record 326072. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/326072
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Malaria | Major topic |
| Primaquine | Major topic |
| Adult | |
| Clinical Trials as Topic | |
| Drug Evaluation | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Plasmodium vivax | |
| Recurrence | |
| Time Factors |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40112852 | 14 days of high-dose versus low-dose primaquine treatment in patients with Plasmodium vivax infection in Cambodia: a randomised, single-centre, open-label efficacy study. | Lancet Infect Dis | 2025 | https://conductscience.org/library/papers/40112852 | PubMed |
| 31274189 | Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria. | Cochrane Database Syst Rev | 2019 | https://conductscience.org/library/papers/31274189 | PubMed |
| 31031463 | Population pharmacokinetics of primaquine and the effect of hepatic and renal dysfunction: An exploratory approach. | Indian J Pharmacol | 2019 | https://conductscience.org/library/papers/31031463 | PubMed |
| 30952158 | Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria. | Clin Infect Dis | 2019 | https://conductscience.org/library/papers/30952158 | PubMed |
| 29510711 | The ethics of using placebo in randomised controlled trials: a case study of a Plasmodium vivax antirelapse trial. | BMC Med Ethics | 2018 | https://conductscience.org/library/papers/29510711 | PubMed |
| 29317838 | Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname. | Infect Drug Resist | 2018 | https://conductscience.org/library/papers/29317838 | PubMed |
| 27708191 | Diagnosis and Treatment of Plasmodium vivax Malaria. | Am J Trop Med Hyg | 2016 | https://conductscience.org/library/papers/27708191 | PubMed |
| 26666941 | Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26666941 | PubMed |
| 24752682 | Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru. | Am J Trop Med Hyg | 2014 | https://conductscience.org/library/papers/24752682 | PubMed |
| 24189254 | Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24189254 | PubMed |
| 24163057 | Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/24163057 | PubMed |
| 22900786 | Primaquine radical cure of Plasmodium vivax: a critical review of the literature. | Malar J | 2012 | https://conductscience.org/library/papers/22900786 | PubMed |
| 22701198 | Failure of Supervised Chloroquine and Primaquine Regimen for the Treatment of Plasmodium vivax in the Peruvian Amazon. | Malar Res Treat | 2012 | https://conductscience.org/library/papers/22701198 | PubMed |
| 19597012 | Resistance to therapies for infection by Plasmodium vivax. | Clin Microbiol Rev | 2009 | https://conductscience.org/library/papers/19597012 | PubMed |
| 18165478 | Vivax malaria: neglected and not benign. | Am J Trop Med Hyg | 2007 | https://conductscience.org/library/papers/18165478 | PubMed |
| 17336652 | Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. | Lancet | 2007 | https://conductscience.org/library/papers/17336652 | PubMed |
| 15695723 | Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax. | J Clin Microbiol | 2005 | https://conductscience.org/library/papers/15695723 | PubMed |
| 11527798 | Plasmodium vivax polymorphism in a clinical drug trial. | Clin Diagn Lab Immunol | 2001 | https://conductscience.org/library/papers/11527798 | PubMed |
| 10488189 | Usefulness of seminested multiplex PCR in surveillance of imported malaria in Spain. | J Clin Microbiol | 1999 | https://conductscience.org/library/papers/10488189 | PubMed |
| 10461431 | Imported tertian malaria resistant to primaquine. | Korean J Intern Med | 1999 | https://conductscience.org/library/papers/10461431 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| G6PD | 2539 | PubTator's text mining | https://conductscience.org/library/genes/2539 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/326072
GET https://conductscience.org/api/papers/v1/326072/cited_by?page=2